Acne Medication Market - Rise in Adoption of Skin Care Products, And Unhealthy Urban Lifestyle That Leads To Acne Development Are the Factors That Boost the Market Growth

The market for Acne Medication is expected to reach $ 10,929 million by the year 2025, an average of 3.9% from 2018 to 2025.

Acne is a long-lasting skin disorder caused by blocked hair follicles, dead skin cells and skin oils. It is characterized by the possibility of a large number of acne, whiteheads, blackheads, oily skin and scars. It usually affects the skin with a relatively large number of glands in the chest, back and upper parts of the face. Acne treatment is a medication used to treat acne. These include retinoids, isotretinin, antibiotics, salicylic acid, benzoyl peroxide, oral contraceptives, and other prescription and over-the-counter medicines.

Factors driving the growth of the acne relief market include the spread of pandemics, an unhealthy urban lifestyle, increased pollution, and increased interest in skin care products. However, the presence of alternative therapies such as acne treatment and remedies and side effects associated with laser therapy hinders market growth. Conversely, the development of new products with fewer side effects and the presence of emerging economies' undeveloped markets are expected to provide favorable market growth opportunities.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/4356?utm_source=sy-Openpr

The key players of this market include
• Allergan Plc.
• Nestle S.A. (Galderma S.A.)
• Johnson & Johnson
• Mayne Pharma Group Limited
• Mylan N.V.
• Pfizer Inc.
• GlaxoSmithKline Plc (Stiefel Laboratories Inc.)
• Sun Pharmaceutical Industries Limited
• Teva Pharmaceutical Industries Ltd.
• Valeant Pharmaceuticals International Inc.

The retinoids segment accounted for the largest share in 2017, owing to high usage in treatment of acne and lesser side effects as compared to other therapeutics. However, the salicylic acid segment is expected to grow at the high CAGR from 2018 to 2025.

The inflammatory acne segment is the largest acne type segment in the global acne medication market in 2017 and is expected to maintain its lead in the forecast period. On the other hand, non-inflammatory acne segment is anticipated to record the highest CAGR from 2018-2025.

By type, the prescription medicine segment dominated the global acne treatment market in terms of revenue in 2017 and the trend is projected to continue throughout the forecast period.
The utilization rate of topical medications for acne treatment is high owing to high availability of these products with high success rate and lesser side effects. However, the oral medication segment is expected to grow at a CAGR of 3.6% during the forecast period.

Make an Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/4356?utm_source=sy-Openpr

Key Findings of the Acne Medication Market:
• The antibiotics segment accounted for nearly one-fourth share of the global acne medication market in 2017.
• The over-the-counter medicine segment is expected to grow at a CAGR of 2.9% from 2018 to 2025.
• The non-inflammatory acne segment accounted for around two-fifths share of the global market in 2017.
• Europe accounted for around one-fourth share of the global market in 2017.
• LAMEA is expected to provide lucrative market growth opportunities and grows with the CAGR of 4.5% from 2018 to 2025.

North America was the leading revenue contributor to the global acne medication market in 2017, and is expected to dominate the market during the forecast period. This is attributed to the early approval of acne medication products and high adoption of prescription medicines in this region. However, Asia-Pacific is expected to grow at the highest CAGR of 5.6% during the study period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness toward safe acne medications products.

Access Full Summery @ https://www.alliedmarketresearch.com/acne-medication-market?utm_source=sy-Openpr

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.